Optimizing cardiovascular risk reduction during antihypertensive therapy.
نویسندگان
چکیده
منابع مشابه
Optimizing cardiovascular risk reduction during antihypertensive therapy.
Over the past decade, pharmacological treatment of elevated blood pressure has evolved from empiricism to a more individualized approach based on patient characteristics and an expanding understanding of the impact of specific agents on the pathophysiology of hypertension and, more importantly, cardiovascular disease. Although blood pressure elevation has been shown to be a powerful risk factor...
متن کاملCombining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
Clinical guidelines now recognize the importance of a multifactorial approach to managing cardiovascular (CV) risk. This idea was taken a step further with the concept of the Polypill™. There are, however, considerable patent, pharmacokinetic, pharmacodynamic, registration, and cost implications that will need to be overcome before the Polypill™ or other single-pill combinations of CV medicatio...
متن کاملAntihypertensive therapy and the risk of malignancies.
AIMS To assess the relationship between antihypertensive therapy and malignancy. METHODS AND RESULTS A MEDLINE search for English-language articles published between January 1966 and August 1999 identified 29 prospective studies that reported cancer incidence or mortality and 28 case-control studies that reported specific drug use in cancer patients and controls. The association between rauwo...
متن کاملGuidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk.
It has been suggested that selection for antihypertensive therapy should be based on absolute risk of a cardiovascular disease (CVD) event and that treatment should be offered only if the 10-year risk exceeds 20%. Although interesting and challenging, this strategy would have the effect of greatly emphasizing treatment of the elderly and downplaying treatment of the middle-aged. It is argued in...
متن کاملWhen does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk.
The report in this issue of Hypertension by Verdecchia et al,1 a prospective study in a relatively large group of patients with uncomplicated essential hypertension, demonstrated two important findings. First, baseline level of plasma glucose and use of diuretics after a median follow-up of 6 years were independent predictors for development of new onset diabetes. Second, they observed that the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hypertension
سال: 1990
ISSN: 0194-911X,1524-4563
DOI: 10.1161/01.hyp.16.2.201